Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

Published:2014-02 Issue:2 Volume:14 Page:109-118
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Fry Alicia M,Goswami Doli,Nahar Kamrun,Sharmin Amina Tahia,Rahman Mustafizur,Gubareva Larisa,Azim Tasnim,Bresee Joseph,Luby Stephen P,Brooks W Abdullah

Funder

Centers for Disease Control and Prevention, Atlanta, GA, USA

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference26 articles.

1. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections;Hayden;N Engl J Med,1997

2. Oral oseltamivir treatment of influenza in children;Whitley;Pediatr Infect Dis J,2001

3. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial;Treanor;JAMA,2000

4. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial;Nicholson;Lancet,2000

5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections;Monto;J Infect Dis,1999

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Nonprescription of Oseltamivir for Infant Influenza Over 9 Seasons;Journal of the Pediatric Infectious Diseases Society;2024-08-21

2. Considerations when treating influenza infections with oseltamivir;Expert Opinion on Pharmacotherapy;2024-07-02

3. Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza;JAMA Internal Medicine;2024-01-01

4. Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season;Pediatria i Medycyna Rodzinna;2023-12-29

5. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults—A randomized blinded controlled trial;Frontiers in Medicine;2023-04-17